PLoS ONE (Jan 2014)

Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumonia.

  • Anne Mehl,
  • Peyman Ghorbani,
  • David Douda,
  • Hailu Huang,
  • Nades Palaniyar,
  • Felix Ratjen,
  • Hartmut Grasemann

DOI
https://doi.org/10.1371/journal.pone.0090232
Journal volume & issue
Vol. 9, no. 3
p. e90232

Abstract

Read online

RationaleInfection of the lung with Pseudomonas aeruginosa results in upregulation of nitric oxide synthases (NOS) and arginase expression, and both enzymes compete for L-arginine as substrate. Nitric oxide (NO) production may be regulated by arginase as it controls L-arginine availability for NOS. We here studied the effect of systemic arginase inhibition on pulmonary L-arginine metabolism in Pseudomonas pneumonia in the mouse.MethodsMice (C57BL/6, 8-10 weeks old, female) underwent direct tracheal instillation of Pseudomonas (PAO-1)-coated agar beads and were treated by repeated intra-peritoneal injections of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) or PBS until lungs were harvested on day 3 of the infection. L-arginine metabolites were quantified using liquid chromatography-tandem mass spectrometry, NO metabolites nitrate and nitrite by Griess reagent and cytokines by ELISA.ResultsNO metabolite concentrations (48.5±2.9 vs. 10.9±2.3 µM, pConclusionsSystemic arginase inhibition with ABH during Pseudomonas pneumonia in mice results in an increase in pulmonary NO formation but no pro-inflammatory effect.